- Home
- MOGO vs IBIO Comparison
MOGO vs IBIO Comparison
Compare MOGO & IBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOGO
- IBIO
- Stock Information
- Founded
- MOGO 2003
- IBIO 2008
- Country
- MOGO Canada
- IBIO United States
- Employees
- MOGO N/A
- IBIO N/A
- Industry
- MOGO
- IBIO Biotechnology: Pharmaceutical Preparations
- Sector
- MOGO
- IBIO Health Care
- Exchange
- MOGO Nasdaq
- IBIO Nasdaq
- Market Cap
- MOGO 25.1M
- IBIO 24.3M
- IPO Year
- MOGO N/A
- IBIO N/A
- Fundamental
- Price
- MOGO $0.89
- IBIO $4.12
- Analyst Decision
- MOGO Strong Buy
- IBIO Strong Buy
- Analyst Count
- MOGO 1
- IBIO 3
- Target Price
- MOGO $4.00
- IBIO $4.87
- AVG Volume (30 Days)
- MOGO 56.6K
- IBIO 423.7K
- Earning Date
- MOGO 03-20-2025
- IBIO 05-12-2025
- Dividend Yield
- MOGO N/A
- IBIO N/A
- EPS Growth
- MOGO N/A
- IBIO N/A
- EPS
- MOGO N/A
- IBIO N/A
- Revenue
- MOGO $29,244,391.00
- IBIO $375,000.00
- Revenue This Year
- MOGO $78.36
- IBIO $36.00
- Revenue Next Year
- MOGO N/A
- IBIO $33.33
- P/E Ratio
- MOGO N/A
- IBIO N/A
- Revenue Growth
- MOGO 1.46
- IBIO 650.00
- 52 Week Low
- MOGO $0.84
- IBIO $1.50
- 52 Week High
- MOGO $2.07
- IBIO $6.89
- Technical
- Relative Strength Index (RSI)
- MOGO 39.22
- IBIO 43.57
- Support Level
- MOGO $0.84
- IBIO $3.80
- Resistance Level
- MOGO $1.00
- IBIO $4.74
- Average True Range (ATR)
- MOGO 0.07
- IBIO 0.47
- MACD
- MOGO 0.00
- IBIO -0.15
- Stochastic Oscillator
- MOGO 14.11
- IBIO 19.13
About MOGO Mogo Inc.
Mogo Inc is a Canadian-based financial technology company. It offers a finance application to consumers with solutions that help them to control their financial health. At Mogo, users can sign up for a free account and get access to products and solutions that help users to monitor their credit score, protect themselves from identity fraud, control their spending, and borrow responsibly. Company offers digital loans and mortgages and also offer a digital payments platform that powers next-generation card programs for both established global corporations and innovative fintech companies in Europe and Canada.
About IBIO iBio Inc.
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.